This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
This page refreshes automatically every 30 mins. Press F5 to update manually
For a more detailed explanation of Upgrades/Downgrades see Link
Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained
| Aggreko | Credit Suisse downgrades to underperform from neutral; cuts TP to 1400p from 2000p |
| Associated British Foods | Nomura ups TP to 1670p from 1650p, reduce |
| Aviva | Berenberg downgrades to sell from Hold |
| Bunzl | Deutsche Bank ups TP to 1426p from 1160p, Hold |
| Burberry | Nomura ups TP to 1630p from 1540p, neutral |
| EVRAZ | Citigroup downgrades to neutral from Buy; TP to 159P from 221P |
| G4S | UBS ups TP to 250p from 230p, neutral |
| GlaxoSmithKline | Deutsche Bank ups TP to 1960p from 1850p, Buy |
| Glencore Xstrata | UBS downgrades to neutral from Buy |
| Glencore Xstrata | Credit Suisse ups TP to 400p from 380p, outperform |
| Go-Ahead Group | JP Morgan ups to overweight from neutral |
| ITV | Liberum ups TP to 230p from 200p, Buy |
| Legal & General | Berenberg ups TP to 225p from 210p, Buy |
| National Express | JP Morgan ups TP to 280p from 219p, neutral |
| Old Mutual | ABSA Capital cuts TP to 225p from 240p, overweight |
| Resolution | Berenberg downgrades to sell from Hold |
| Royal Bank of Scotland | UBS downgrades to neutral from Buy |
| Serica Energy | RBC cuts TP to 35p from 40p, outperform |
| Severstal | Citigroup downgrades to neutral from Buy |
| St. James’s Place | Berenberg ups to Buy from Hold |
| Stagecoach Group | JP Morgan ups to overweight from neutral |
| Standard Life | Berenberg ups to Hold from sell |
| Vesuvius | Morgan Stanley downgrades to underweight from Equalweight, ups TP to 425p from 369p |
| Source: Reuters News, AlphaTerminal, Dow Jones Newswires | |
Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires
T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research